CSINTELL PROVIDES THE CORPORATE STRATEGIC INTELLIGENCE YOU NEED!
CSIntell founded in 2012 by Paul-Emmanuel GOETHALS, aims to provide consultancy services in the areas of strategic intelligence, to become the Intelligence source of choice of SME’s. CSIntell intends to offer advices in strategy, market research, competition analysis, analysis of investment opportunity and potential acquisition, analysis of technological developments.
Information on reports covering
Nuclear Medicine
Cyclotrons
Proton Therapy
Brachytherapy
are available
through MEDraysintell
Vision
The Economic World is more Global than ever, changing constantly and rapidly.
In that world, small-medium sized enterprises (SME) are taking an increasing role and senior management are eager to obtain better, quicker and easier-to-understand information to make the right decision.
Strategic Intelligence for those SME, especially in Medtech, Biotech and Chemtech industries is critical to survive and to growth, it just makes economic sense.
Paul-Emmanuel Goethals founded CSIntell in 2012 and MEDraysintell in 2013, a business acquired by NucAdvisor in 2024. With 36 years of experience in consulting, business development intelligence, and investor relations, he has developed a unique expertise in the medical and healthcare sectors, particularly in radiotherapy and radiopharmacy. Over the course of his career, Paul-Emmanuel has authored numerous in-depth market reports and company profiles, consistently delivering exceptional results and earning the trust and satisfaction of his clients.
Paul-Emmanuel holds an MBA from the University of Dallas and is a member of SCIP (Strategic and Competitive Intelligence Professionals, Texas, USA).
Following the acquisition of MEDraysintell by NucAdvisor, Paul-Emmanuel Goethals continues to drive the advancement of the Nuclear Medicine Report & Directory. Before founding MEDraysintell and CSIntell, Paul-Emmanuel held key leadership roles in prominent organizations. He served as Vice President of Business Development & Capital Markets and Special Counsel to the CEO at Eckert & Ziegler Group, a European company listed in Frankfurt and active in cancer therapy, radiometry, and nuclear-medical imaging (2009-2012). Prior to that, he was Director of Corporate Business Development & Investor Relations at IBA, a Belgian company listed in Brussels, specializing in proton therapy, radiopharmacy, dosimetry, and industrial sterilization (1998-2009). Earlier in his career, Paul-Emmanuel was a Project Manager at Strategic Analysis Inc., a U.S.-based management consulting firm focused on chemical and pharmaceutical business intelligence (1994-1998). He also served as Finance Director and Board Member at Evening Group SA, a Belgian business events company (1992-1993), and as Marketing Specialist & Product Manager at Chemviron Carbon, the European division of a U.S. chemical group (1989-1992).
Contact
Paul-Emmanuel GOETHALS, MBA
Phone: +32 491 080 968
paul@csintell.com
Louvain-la-Neuve, BELGIUM